Causal variance decompositions for institutional comparisons in
  healthcare by Chen, Bo et al.
Causal variance decompositions for institutional
comparisons in healthcare
Bo Chen1, Keith A. Lawson2, Antonio Finelli2, and Olli Saarela∗1
1Dalla Lana School of Public Health, University of Toronto
2Princess Margaret Cancer Centre, University Health Network
September 6, 2019
Abstract
There is increasing interest in comparing institutions delivering healthcare
in terms of disease-specific quality indicators (QIs) that capture processes or
outcomes showing variations in the care provided. Such comparisons can be
framed in terms of causal models, where adjusting for patient case-mix is anal-
ogous to controlling for confounding, and exposure is being treated in a given
hospital, for instance. Our goal here is to help identifying good QIs rather than
comparing hospitals in terms of an already chosen QI, and so we focus on the
presence and magnitude of overall variation in care between the hospitals rather
than the pairwise differences between any two hospitals. We consider how the
observed variation in care received at patient level can be decomposed into that
causally explained by the hospital performance adjusting for the case-mix, the
case-mix itself, and residual variation. For this purpose, we derive a three-way
variance decomposition, with particular attention to its causal interpretation
in terms of potential outcome variables. We propose model-based estimators
for the decomposition, accommodating different link functions and either fixed
or random effect models. We evaluate their performance in a simulation study
and demonstrate their use in a real data application.
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1 Introduction
1.1 Background
Striving for accountability and transparency in healthcare has increased the interest
in quantifying and comparing the performance of institutions in terms of the quality
of care that the patients receive. This is commonly done in terms of disease-specific
quality indicators (QIs) that measure structural, process or outcome elements related
to the care of a particular condition [1]. For instance, in the context of surgical care
for kidney cancer, examples would be (i) proportion of partial versus radical nephrec-
tomies for early-stage patients with chronic kidney disease risk factors, (ii) proportion
of minimally invasive versus open radical nephrectomies for early-stage patients, (iii)
average length of stay after a radical nephrectomy or (iv) proportion of unplanned
readmissions within 30 days of a radical nephrectomy [2]. Process measures may be
preferred for measuring quality for the reason that they are directly related to clinical
decisions and thus are more actionable [3]. However, even before considering improv-
ing quality, the chosen indicator has to demonstrate existing differences in the quality
of care. In doing so, it already answers a causal question, namely “would a patient
receive different care if treated in a different hospital?”. The goal of the present work
is developing metrics and statistical methods that can help to identify processes or
outcomes that can capture variation in the quality of care between hospitals. Follow-
ing Varewyck et al. [4], this can be framed in a causal inference framework, where
adjusting for patient case-mix factors is analogous to controlling for confounding.
However, since our focus is in choosing QIs, rather than comparing or ranking hos-
pitals in terms of an already chosen metric, we are interested in the presence and
magnitude of overall variation between the hospitals, rather than contrasts between
any two hospitals. While we restrict the discussion to between hospital comparisons,
without loss of generality the methods would also apply to other comparisons in the
healthcare system, such as administrative subregions or individual providers (such as
surgeons).
Variance decompositions have been used in the hospital profiling context to mea-
sure reliability of rankings in terms of a given quality indicator (rankability)[5, 6, 7],
though this decomposition is constructed at aggregate (hospital) level rather than
at individual patient level. This approach broadly corresponds to the random effect
meta-analysis model, where the case-mix adjusted hospital-specific quality indicators
θˆz are assumed to follow the model θˆz = θ0 + θz + ξz, where z = 1, . . . ,m is used
to index the hospital and m stands for the total number of hospitals. In this model,
θz ∼ N(0, τ 2) is a normally distributed hospital effect (‘heterogeneity’) around the
average performance θ0, and ξz ∼ N(0, s2z) reflects the sampling variation under the
‘null’ of no hospital effect (τ 2 = 0). For instance, following van Houwelingen and
Brand [5] and Racz and Sedransk [8], to obtain an indirectly standardized proportion
type quality indicator, one could take θˆz = p
Oz
Ez
, where the overall proportion p in
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the entire patient population is multiplied by the standardized ratio of observed to
expected counts. The observed count for hospital z is given by Oz =
∑n
i=1 1{Zi=z}Yi,
where Yi is the process/outcome measure of interest, and Zi indicates the hospital
where patient i ∈ {1, . . . , n} was treated, with n being the size of the overall patient
population serving as the standard population (e.g. combination of patient popula-
tions from hospitals in a given administrative region). The expected count is given
by Ez =
∑n
i=1 1{Zi=z}pˆii, where pˆii = expit(αˆ0 + βˆ
′Xi) is a prediction from a logistic
regression model adjusted for the case-mix factors Xi, but not including the hospital
indicators. Supposing that the standard population is large enough to ignore estima-
tion uncertainty in the expected counts, we can take s2z =
p2
E2z
∑n
i=1 1{Zi=z}pˆii(1− pˆii),
with τ 2 reflecting the between-hospital variation after adjusting for patient case-mix.
The latter in turn can be estimated using the DerSimonian & Laird method [9] or
maximum likelihood, with the meta-analysis I2 statistic indicating the proportion of
variation due to between-hospital heterogeneity.
Closely related, but defined at individual level, is the concept of intra-class cor-
relation (ICC), commonly estimated through mixed effect models [10, 11, 12, 13, 14,
15, 16]. Consider a generalized linear mixed effect model (GLMM)
E[Yi | Zi = z,Xi] = g−1 (α0 + αz + β′Xi) , (1)
where g() is the link function, and Yi, Zi, and Xi are as before. The hospital level
intercept terms are taken to follow αz ∼ N(0, τ 2), z = 1, . . . ,m. For instance, with
an identity link and residual variation distributed as εi ∼ N(0, σ2), we have that the
conditional correlation cor(Yi, Yi′ | Zi = Zi′ = z,Xi, Xi′) = τ 2/(τ 2 + σ2). That is,
the conditional correlation of the outcomes of two individuals treated in the same
hospital is equal to the proportion of between-hospital variance of the total variance
left after controlling for the patient case-mix, and can be estimated by fitting the
random intercept model to obtain estimates for τ 2 and σ2. However, the connection
between the ICC and the random intercept variance is more complicated with non-
identity links, as the variance decomposition is different at the linear predictor and
link function scale [17, 18]. An attempt for interpretation of the between cluster
variance in terms of more familiar effect measures are the median odds ratio and
median hazard ratio for binary outcomes and time-to-event outcomes, respectively
[19]. We opt to take another route of considering the causal interpretation of the
variance decomposition, as well as estimation methods that are invariant to the choice
of the link function.
Furthermore, two-way variance decompositions generalize mathematically into ar-
bitrary multi-way decompositions, though these depend on the chosen order of fac-
torization [20]. Aligned with our goal of identifying QIs that can capture between-
hospital variation in quality without being completely driven by the case-mix, we are
interested in decomposing the observed variation in care received to that explained
by patient case-mix, causal between-hospital variation given the case-mix and unex-
plained (residual) variation.
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1.2 Objectives
Summarizing the objectives motivated above, the structure of the paper is as fol-
lows. In Section 2.1 we recapitulate the potential outcomes (Rubin’s) causal model
[21], the related assumptions, and its extensions to between hospital comparisons fol-
lowing Varewyck et al. (2014) [4]. In Section 2.2, we introduce the causal variance
decomposition to partition observed variation in care received, and discuss its inter-
pretation in Section 2.3. In Section 2.4, we investigate the connection between our
causal variance decomposition and the ICC. In Section 3, we propose model-based es-
timation methods for the variance decompositions, and investigate their performance
in a simulation study in Section 4 and illustrate them in a real data application in
Section 5. We conclude with a brief discussion on limitations and future directions
in Section 6.
2 Proposed measures
2.1 Notation and assumptions
Suppressing the individual-level indices i until the discussion of estimators in Section
3, let Y ∈ R represent the observed process or outcome experienced by a given
patient, used to construct a quality indicator. Let Y (z) ∈ R represent the potential
counterpart of this had the same patient received care in hospital z ∈ {1, ...,m}. Let
further X = (X1, .., Xp) be a vector of covariates relevant to the case-mix adjustment
(including information on demographics, comorbidities, and disease progression), and
let Z ∈ {1, ...,m} indicate the hospital in which the patient was actually treated.
Under counterfactual consistency/stable unit treatment value assumption (SUTVA),
the observed outcome is related to the potential outcomes by Y = Y (Z). We assume
the strong ignorability of the hospital assignment mechanism, which states that 0 <
P (Z = z | X = x) < 1 (positivity) and Y (z) ⊥ Z | X (conditional exchangeability)
at all combinations of z and x[21, 22]. We note that as long as these conditions
are satisfied, the actual mechanism which assigns patients to hospitals can be more
complicated without biasing the inferences. For example, adapting from Moreno-
Betancur et al.[23], the causal relationships in the case of a process type indicator
could be as illustrated in the directed acyclic graph (DAG) of Figure 1. Here the
additional variables in history H reflect the history (including family history) of an
individual contributing to that individual living in a particular area indicated by I
(e.g. postal code), which in turn in part contributes to the individual being treated
in a particular hospital in that area. In this DAG, X are sufficient to control for
confounding of the hospital effects, while I are instrumental variables rather than
confounders, and adjusting for them would likely lead to positivity violations.
4
XZ Y
I
H
Figure 1: Causal mechanism for hospital assignment (Z) and a process type indicator
(Y ). Here X represents a vector of potential confounders relevant to the case-mix
adjustment, while I represents instrumental variables that predict the hospital as-
signment but are not confounders. H represents latent history that can influence I
and X but is not in itself confounder.
2.2 Three-way causal decomposition for observed variation
in care received
We are interested in decomposing the observed variance in the care received, V [Y ],
to that causally explained by the quality of care differences between hospitals, by
individual-level case-mix factors, and residual variation. Under the counterfactual
consistency, V [Y ] = V [Y (Z)], for which we can write the usual two-way variance
decomposition
V [Y (Z)] = VX [E(Y (Z) | X)] + EX [V (Y (Z) | X)]. (2)
For the first term, we can further write
E(Y (Z) | X) = EZ|X [E(Y (Z) | Z,X)], (3)
and for the latter term,
V (Y (Z) | X) = VZ|X [E(Y (Z) | Z,X)] + EZ|X [V (Y (Z) | Z,X)]. (4)
Substituting (3) and (4) into Equation (2), we obtain
V [Y (Z)] =VX{EZ|X [E(Y (Z) | Z,X)]}+ EX{VZ|X [E(Y (Z) | Z,X)]}
+ EZ,X [V (Y (Z) | Z,X)].
(5)
Here, due to strong ignorability, we have
E(Y (z) | Z = z,X) = E(Y (z) | X) and V (Y (z) | Z = z,X) = V (Y (z) | X).
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Applying these, we get the following result:
V [Y ] = VX
{∑
z
E(Y (z) | X)P (Z = z | X)
}
+ EX
∑
z
[
E(Y (z) | X)−
∑
z′
E(Y (z′) | X)P (Z = z′ | X)
]2
P (Z = z | X)

+ EX
{∑
z
V (Y (z) | X)P (Z = z | X)
}
.
We will consider the second term on the right had side as the causal quantity of
interest. In this, the hospital specific performance is compared to the the expected
level of care in the system for a patient with covariate values X, and then averaged
over the covariate distribution of the standard population, similar to direct standard-
ization. We note that this quantity is expressed in terms of potential outcomes and
is a causal quantity in its own right, that is, it can be defined regardless of the causal
assumptions. The causal assumptions are used to link this estimand to the observed
data, working backwards to V [Y ]. For the decomposition, we get the interpretation
V [Y ] = total observed variance in care received
= variance explained by the patient case-mix
+ average variance causally explained by the between-hospital differences in performance
conditional on case-mix
+ unexplained (residual) variance.
The estimation of the components is discussed in Section 3. Briefly, the estimation
of the variance decomposition can be based on modeling the components E[Y | Z,X]
and P (Z | X) combined with the empirical distribution of X. Alternatively, because
the decomposition can be also expressed as
V [Y ] = VX {E(Y | X)}+ EZ,X
{
[E(Y | Z,X)− E(Y | X)]2}+ EZ,X {V (Y | Z,X)} ,
the estimation can also be based on modeling E[Y | Z,X] and E[Y | X] combined
with the empirical distribution of (Z,X). In Section 3 we choose the former ap-
proach because it corresponds to the factorization of the likelihood, and thus enables
approximate Bayesian inference. Before this, we further discuss the interpretation of
the second term in the decomposition as a causal estimand.
2.3 Causal interpretation of the decomposition
To understand the causal interpretation of the variance decomposition, it is helpful
to consider the special case of two hospitals, in which case the second term of the
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decomposition should reduce into a pairwise causal contrast. With two hospitals
indexed by z = 1, 2 and denoting the propensity score P (Z = 1 | X) = pi(X), the
first term of the decomposition becomes
VX
{∑
z
E(Y (z) | X)P (Z = z | X)
}
= VX {pi(X)E(Y (1) | X) + (1− pi(X))E(Y (2) | X)} ,
and the second term
EX

2∑
z=1
[
E(Y (z) | X)−
2∑
z′=1
E(Y (z′) | X)P (Z = z′ | X)
]2
P (Z = z | X)

= EX
{
pi(X)(1− pi(X)) [E(Y (1) | X)− E(Y (2) | X)]2}
= EX
{
V (Z | X) [E(Y (1) | X)− E(Y (2) | X)]2} .
Now, we consider three different scenarios based on the relationships between Y , Z
and X in Figure 1.
Scenario 1. In the absence of the arrow X → Y , which implies Y ⊥ X | Z and
E(Y (z) | X) = E(Y (z)), the first term is equal to VX(pi(X)) [E(Y (1))− E(Y (2))]2.
This implies that this term takes the variance contribution of the indirect (me-
diated) pathway X → Z → Y , which is present only if Z has causal effect on
Y . The second term is equal to EX [V (Z | X)][E(Y (1))−E(Y (2))]2. The differ-
ence in interpretation between these two terms is that the former represents the
variance due to different kinds of patients being treated by different hospitals,
while the latter represents the variation in care similar patients receive. If all
hospitals treat similar patient populations, the former term disappears, while
the latter is maximized. In the opposite case where the hospitals specialize in
treating different patient populations, the positivity assumption is violated and
the process/outcome cannot reveal performance differences between the hospi-
tals. Thus, we focus on the second term as a measure of goodness of a proposed
process/outcome as a QI.
Scenario 2. In the absence of the arrows X → Z and I → Z, which implies Z ⊥ X
and pi(X) = pi (randomized assignment), the first term would be equal to
VX {pi[E(Y (1) | X)− E(Y (2) | X)] + E(Y (2) | X)}. The two additive compo-
nents inside the variance reflect the effect modification by X and the predictive
variance due to X. In the absence of effect modification/additive interaction,
that is, E(Y (2) | X) = E(Y (1) | X) + α, it follows that pi[E(Y (1) | X) −
E(Y (2) | X)] = piα is constant and only the predictive variance remains. The
second term is equal to V (Z)EX
{
[E(Y (1) | X)− E(Y (2) | X)]2}. In the ab-
sence of effect modification, this becomes pi(1−pi)α2, capturing the causal effect.
Compared to the usual direct standardization formula E(Y (1)) − E(Y (2)) =
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EX [E(Y (1) | X) − E(Y (2) | X)], the between-hospital variance is similarly
averaged over X, but squared so that any contrast at the same level of X
contributes to the variance rather than canceling out. The reason effect modifi-
cation contributes to both case-mix and between-hospital variance components
is that it both increases the variance of the expected care level (non-causal)
and the average squared difference from the expected care level (causal). When
evaluating proposed processes/outcomes, we would again want the second term
to be comparatively large compared to the first one, because even though the
eventual QI will be case-mix adjusted, large case-mix variance indicates that the
measure is less intervenable, as the variation in care largely reflects treatment
choices necessitated by disease progression, comorbidities etc., and makes the
indicator sensitive to the method of case-mix adjustment.
Scenario 3. In the absence of the arrow Z → Y , which implies Y ⊥ Z | X and
E(Y (1) | X) = E(Y (2) | X), the first term becomes VX [E(Y (2) | X)], reflecting
the predictive variance due to X, while the second term is equal to zero as it
should in the absence of causal effect of Z on Y .
2.4 Connection to intra-class correlation
We note that the previously derived variances were weighted by the quantities P (Z =
z | X) reflecting the hospital patient volumes; this is natural since we are decomposing
the observed variance in the entire combined patient population, and larger centers
carry more weight in this. However, to expand the proposed framework, we can con-
sider variance decompositions under hypothetical assignment mechanisms that can
differ from the actual one. For example, referring to the interpretation of Scenario
1 of Section 2.3, we can consider the variance decomposition under a hypotheti-
cal ‘randomized’ assignment mechanism where every hospital treats similar kind of
patient population. This also allows us to derive a connection between the causal
between-hospital variance in the previous section, and the more familiar intraclass
correlation. Let A represent a random draw from such a hypothetical assignment
mechanism, with the mechanism chosen so that A ⊥ Z | X, and strong ignorability
0 < P (A = a | X = x) < 1 and Y (a) ⊥ A | X apply. This lets us consider random
draws of potential outcomes Y (A), similar to the notation used by VanderWeele et
al.[24]. Now, because
E(Y (a) | A = a,X) = E(Y (a) | X) = E(Y (a) | Z = a,X),
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we can write the variance decomposition
V [Y (A)] = VX
{∑
a
E(Y (a) | X)P (A = a | X)
}
+ EX
∑
a
[
E(Y (a) | X)−
∑
a′
E(Yi(a
′) | X)P (A = a′ | X)
]2
P (A = a | X)

+ EX
{∑
a
V (Y (a) | X)P (A = a | X)
}
.
If we choose here P (A = a | X) = P (Z = a | X) ∀ a ∈ {1, . . . ,m}, the result
is equivalent to before. However, if we choose to weight the hospitals equally as
P (A = a | X) = 1/m, and assume a linear model
E(Y (a) | Z = a,X) = E(Y (a) | X) = α0 + αa + β′X,
we can express the second term as
EX
∑
a
[
E(Y (a) | X)−
∑
a′
E(Y (a′) | X)P (A = a′ | X)
]2
P (A = a | X)

= EX
 1m∑
a
[
E(Y (a) | X)− 1
m
∑
a′
E(Y (a′) | X)
]2
=
1
m
∑
a
[
αa − 1
m
∑
a′
αa′
]2
. (6)
If we take the hospital effects to represent a ‘sample’ from a distribution with variance
V [αa] = τ
2, (6) converges to τ 2 when m→∞. In reality, since our discussion is in the
administrative data context, we observe all the hospitals in the administrative region
of interest and don’t take them to be a sample from a superpopulation of hospitals.
Nevertheless, the result serves to establish a connection to the ICC: because
V (Y (A) | X) = VA|X [E(Y (A) | A,X)] + EA|X [V (Y (A) | A,X)]
→ τ 2 + σ2 when m→∞,
under a linear model the causal interpretation of ICC = τ
2
τ2+σ2
is the proportion
of case-mix conditional variance that is causally explained by the between-hospital
variation in practices. However, this interpretation is specific to the linear model with
equal hospital weights, which is why we proceed with the decomposition in Section
2.2 for the observed variance; this is general and can be estimated in the same way
irrespective of the outcome model formulation (that is, irrespective of the choice of
the link function, or whether the hospital effects are modeled as fixed or random
effects).
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3 Estimators
3.1 Point estimators
We present model-based direct standardization type estimators for the variance com-
ponents. To model the outcomes, we specify a generalized linear model
E[Y (z) | X; θ] = E[Y | Z = z,X; θ] = g−1 (α0 + αz + β′X) ,
where θ = (α0, α1, . . . , αm, β). The hospital level intercept terms αz, z ∈ {1, ...,m}
are either fixed, with α1 = 0, or follow αz ∼ N(0, τ 2) (random intercept model). As
noted in the previous section, the random effects are adopted as a means to apply
shrinkage to the hospital effects, rather than a data generating mechanism. With
random effects, the fitted values are obtained using empirical Bayes prediction for the
random intercepts. We note that in the model we can also introduce hospital-case-mix
interactions, as discussed by Varewyck et al.[25], but omit these here for notational
simplicity. We estimate the parametrized variance explained by the patient case-mix
as
ω1(θ, η) = VX
{∑
z
E(Y (z) | X; θ)P (Z = z | X; η)
}
≈ 1
n− 1
n∑
i=1
{∑
z
µi(z; θˆ)P (Zi = z | xi; ηˆ)− 1
n
n∑
i′=1
∑
z
µi′(z, θˆ)P (Zi′ = z | xi′ ; ηˆ)
}2
,
where µi(z; θ) = E[Yi | Zi = z, xi; θ] and where the terms P (Z = z | X; η) can be
estimated by fitting a multinomial logistic regression model
P (Z = z | X; η) =

1
1+
∑m
z′=2 exp(γz′+φ
′
z′X)
z = 1
exp(γz+φ′zX)
1+
∑m
z′=2 exp(γz′+φ
′
z′X)
z 6= 1, (7)
where η = (γ2, . . . , γm, φ2, . . . , φm). Similarly, the parametrized average variance
explained by the hospital performance conditioning on patient case-mix can be esti-
mated by
ω2(θ, η) = EX
∑
z
[
E(Y (z) | X; θ)−
∑
z′
E(Y (z′) | X; θ)P (Z = z′ | X; η)
]2
P (Z = z | X; η)

≈ 1
n
n∑
i=1
∑
z
µi(z; θˆ)
2P (Zi = z | xi; ηˆ)−
[∑
z
µi(z; θˆ)P (Zi = z | xi; ηˆ)
]2 .
The residual variance can then be estimated by subtracting the two estimated com-
ponents from the empirical total variance, or using a distributional assumption such
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as V (Yi | Zi = z, xi; θ) = µi(z; θ)[1 − µi(z; θ)] in the case of binary indicator, and
taking
ω3(θ, η) = EX
{∑
z
V (Y (z) | X; θ)P (Z = z | X; η)
}
≈ 1
n
n∑
i=1
{∑
z
µi(z; θˆ)[1− µi(z; θˆ)]P (Z = z | xi; ηˆ)
}
.
3.2 Variance estimators
To quantify the uncertainty in the variance components, we note that conditional
on the empirical covariate distribution in the standard population the estimates are
entirely model-based. Thus, we can produce approximate samples from the joint
posterior distribution
p(θ, η | X,Y,Z) = p(Y,Z | θ, η,X)p(θ | X)p(η | X)
p(Y,Z | X)
=
p(Y | θ,X,Z)p(θ | X)
p(Y | X,Z)
p(Z | η,X)p(η | X)
p(Z | X)
= p(θ | X,Y,Z)p(η | X,Z),
by sampling θ and η separately from their respective posteriors, and recalculate the
variance components ω1(θ, η) and ω2(θ, η) at each combination of θ and η to quantify
uncertainty in them. Under flat priors the sampling distribution variances of the
parameter estimates approximate the respective posterior variances; in approximate
sampling of θ we used parametric bootstrap to reflect the uncertainty in the random
effect estimates; for example for a binary indicator we can repeatedly sample the
outcomes from Yi | (zi, xi; θˆ) ∼ Bernoulli(µi(zi; θˆ)), i = 1, . . . , n, and refit the mixed
model to produce a sample of the model-based fitted values µi(z; θ). Compared to
non-parametric bootstrap this avoids some hospital categories being absent in some
of the replicates. For sampling of η we used the normal approximation η | (X,Z) ∼
N(ηˆ, V (ηˆ)) where ηˆ is the maximum likelihood estimate of η and V (ηˆ) its asymptotic
variance-covariance matrix from the multinomial logistic model fit.
4 Simulation study
4.1 Generating mechanism
We demonstrate the performance of the estimators by simulating data from a generat-
ing mechanism simplified (omitting H and I) from that in Figure 1, varying the total
number of patients n and number of hospitals m. Our objectives in the simulation are
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(a) to demonstrate that the proposed estimators work both for linear models for con-
tinuous outcomes and logistic models for dichotomous outcomes, (b) to demonstrate
that the estimators work both with fixed and random effect models, and (c) to obtain
evidence of their asymptotic behaviour under increasing n and m. First, we generated
two case-mix factors from X1 ∼ N(0, 1) and X2 ∼ Bernoulli(0.5), given which the
hospital assignment Z was generated from multinomial logistic model specified as in
(7), drawing the intercepts from γz ∼ N(0, 0.25) and the regression coefficients from
φz1 ∼ N(0, 0.5) and φz2 ∼ N(0, 0.5), z = 2, . . . ,m. In our generating mechanism, we
did not consider the hospitals themselves to be a sample from a superpopulation of
hospitals, and thus we fixed the hospital-specific parameters across the replications
(i.e. drawing these only once from the above distributions), while resampling the
patients in each replication. This corresponds to conventional analysis of administra-
tive data, where all the hospitals operating in a given region are compared, but the
observed patient population is taken to represent a sample from an unobserved“long
run”. Outcomes were generated from the mean structure
g(E[Y (z) | X; θ]) = αz +X1 + 2X2, (8)
with the hospital effects drawn from αz ∼ N(0, 22) (again fixing these parameter
values across the replications). Continuous potential outcomes were generated by
taking Y (z) = E[Y (z) | X; θ]+ε, where ε ∼ Logistic(0,1), with the observed outcome
given by Y (Z). Binary outcomes were generated by dichotomizing at zero as Y˜ (z) =
1{Y (z)≥0}. To calculate the estimators, correctly specified outcome and assignment
models were fitted to each simulated dataset, with both fixed and random effect
specifications used for the former, whereas the true decomposition was calculated
using the known values fixed in the data generating mechanism.
4.2 Results
4.2.1 Continuous Outcomes
Figure 2 shows the simulated sampling distribution means for the three variance
components under both fixed and random effect models for the continuous outcomes
under different combinations of n and m, based on 1000 replications. Also shown
are the 95% quantile interval for the sampling distribution, and the 95% confidence
interval for the mean of the sampling distribution, reflecting the magnitude of the
Monte Carlo error. The black dots indicate the true variances. The estimators capture
the true value reasonably well in all cases, though with the random effect model giving
slightly smaller estimates for the hospital variance component. Also of note is that
the uncertainty in the variance component estimates is mainly driven by the overall
number of patients n (distributed across the m hospitals) rather than the number of
hospitals m. This is also illustrated in Figure 3 which shows the convergence of the
sampling distributions for the hospital and patient variance components as a function
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of n with fixed m. Finally, as suggested in Section 2.4, in Figure 4 we demonstrate
that the random effect variance τˆ 2 estimates a different quantity than the causal
between-hospital variance in the decomposition; the difference is marked especially
with small number of hospitals.
4.2.2 Binary Outcomes
Figure 5 shows the simulated sampling distribution means for two of the three variance
components under both fixed and random effect models for the binary outcomes under
different combinations of n and m, based on 1000 replications. The results are mostly
similar to the continuous case, with the random effect model giving slightly smaller
estimates for the hospital variance component compared to the fixed effect model.
However, some small sample bias in the hospital variance component (fixed effect
model overestimating and random effect model underestimating) is visible with small
number of patients per hospital (top-right panel, on average 500/25 = 20 patients
per hospital), which disappears with increasing number of patients. The convergence
of the sampling distributions with increasing n is illustrated in the density plots of
Figure 6.
5 Illustration in real data
We demonstrate the use of the proposed three-way causal decomposition in the con-
text of QIs for surgical care of kidney cancer in the province of Ontario. We investigate
four processes/outcomes that have previously been proposed as disease-specific QIs
using the consensus/Delphi method by a panel of experts [2]. These are the propor-
tion of partial (versus radical) nephrectomies among stage T1a nephrectomy patients
(Partial), the same proportion restricted to the subpopulation of patients with chronic
kidney disease (CKD) or its risk factors diabetes or hypertension (Partial-CKD),
minimally invasive (versus open) surgery among T1-T2 radical nephrectomy patients
(MIS), and readmission within 30 days of the surgery for T1-T4 radical nephrectomy
patients (Readmission). The Partial, Partial-CKD and MIS indicators are process
type, with higher proportion reflecting quality of care through kidney function con-
serving and less invasive treatment for early stage patients that can benefit from
this. The Readmission indicator is outcome type, with lower proportion reflecting
quality of care through reduced complications. Our objective in the illustration was
to evaluate the processes/outcomes using the proposed variance decomposition ap-
proach, to quantify how much of the variation in these is between-hospital (reflecting
performance and potentially intervenable), and how much is driven by the patient
case-mix. The data were obtained from cross-linkage of Cancer registry, pathology
reports, Hospital Discharge Abstract (DAD), Ontario Health Insurance Plan (OHIP)
and other databases housed at the Institute for Clinical Evaluative Sciences (ICES).
We included patients who had complete data on the case-mix factors age, sex, income
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quintile, Charlson comorbidity score, ACG comorbidity score, presence of CKD risk
factors (for indicators other than Partial-CKD), days from diagnosis to treatment,
year of diagnosis, tumor size, and T stage. Table 1 shows the number n of patients
identified and hospitals m evaluated for each of the four indicators in the study period
from 1995-2014.
To these data, using the R package VGAM [27], we fitted a multinomial logistic
assignment models where, to deal with empty covariate categories for small volume
hospitals, we estimated only intercept terms for hospitals that had treated less than
35 (40 for MIS) patients over the study period. This is justifiable as our estimators
use the assignment model only for weighting the hospitals by their patient volumes,
whereas the case-mix adjustment is achieved through the outcome model. For the
processes/outcomes, we fitted mixed effects logistic models using the glmer function
of R package lme4 [26], adjusting for the aforementioned covariates. The covariate
effects (log-odds ratios) and their z-scores are reported in Table 1, along with the
likelihood ratio test χ2 values for the random intercept variance parameter in the
models (one degree of freedom). In all cases the likelihood ratio test indicated sta-
tistically significant between hospital variation, but this was much smaller for Read-
mission. Larger tumor size was a very strong predictor of radical nephrectomy, while
both partial nephrectomies and minimally invasive surgeries had become significantly
more common over calendar time. The comorbidity scores were strongest predictors
of readmission.
The empirical proportions of the four indicators and the corresponding marginal
variances were 44.7% and 0.447*(1-0.447)=0.247 (Partial), 43.8% and 0.246 (Partial-
CKD), 63.7% and 0.231 (MIS), and 7.6% and 0.07 (Readmission). Table 2 shows
the estimated three variance components using the proposed decomposition, along
with the 95% credible intervals using the approximate Bayesian method described in
Section 3. We also show the proportional variances along with their credible inter-
vals, because these are more informative for comparing indicators with very different
marginal variance. We note that the estimated components sum up to the empirical
marginal variance given by the binomial calculation. The Partial indicator shows
some between-hospital variation, but this is small compared to the case-mix variance.
This does not change much when this indicator is restricted to the CKD risk factors
subpopulation, because tumor size is the major driver of the large case-mix variance.
These results suggest that even though the indicator was restricted to T4a disease,
the treatment choice seems to be often determined by disease progression. However,
because partial proportion has seen significant increase over calendar time, the case-
mix variance will be smaller when such indicator is applied to contemporary data. In
contrast, the MIS indicator shows between-hospital variance that is almost two times
the case-mix variance, implying lot of variation in care for similar patients. This may
be due to specialization or facilities available, which are intervenable. Because the
calendar year was the biggest driver of the case-mix variance for MIS, the case-mix
variance will be even smaller when indicator is applied to contemporary data. Finally,
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Process/outcome
Covariate
Partial Partial-CKD MIS Readmission
n = 4738 n = 3028 n = 4100 n = 7362
m = 112 m = 110 m = 72 m = 115
χ2 = 377 χ2 = 216 χ2 = 825 χ2 = 16
Male sex 0.21 (2.81) 0.22 (2.39) 0.05 (0.67) -0.02 (-0.18)
Age -0.01 (-4.11) -0.01 (-2.67) -0.01 (-2.06) 0.01 (2.74)
Income quintile 0.03 (1.14) 0.03 (1.07) 0.01 (0.47) <|0.01|(-0.05)
Rural vs urban 0.18 (1.46) 0.20 (1.37) -0.14 (-1.17) -0.18 (-1.33)
Charlson score -0.14 (-4.93) -0.16 (-5.02) -0.11 (-4.37) 0.12 (6.56)
ACG score -0.01 (-1.20) <|0.01|(-0.19) 0.01 (1.61) 0.02 (4.64)
log(dx to tx days+1) 0.02 (1.02) 0.03 (1.41) 0.02 (0.65) 0.09 (3.64)
Year of dx 0.19 (21.87) 0.18 (17.13) 0.20 (15.28) -0.01 (-1.43)
Tumor size (cm) -0.82 (-17.25) -0.75 (-12.87) -0.16 (-7.21) 0.02 (1.44)
CKD risk factors -0.02 (-0.26) - -0.03 (-0.36) 0.15 (1.31)
T2 vs T1 stage - - -0.31 (-2.16) -0.03 (-0.21)
T3 or 4 vs T1 stage - - - 0.19 (-1.60)
Table 1: A summary table of the effects of case-mix factors for the four different QIs.
The numbers are log-odds ratios (z-scores), while m and n represent the number of
hospitals and patients. dx stands for diagnosis and tx for treatment (surgery).
the Readmission indicator shows very little between-hospital variation, suggesting it
is unlikely to be useful in capturing performance related variation.
6 Discussion
In this paper, we aimed to give a causal interpretation to variance decompositions
used to quantify variations in hospital performance, and propose estimators that
can accommodate different link functions, as well as fixed and random effect models
for the hospital effects. The estimation of the hospital variance component worked
reasonably well with the number of hospitals as small as 10. While the random effect
models could introduce some bias to estimation of the variance components when the
hospital-level effects and the patient case-mix are dependent [28], they are helpful for
smoothing purposes when a large number of small volume hospitals are present. Fixed
effect models can accommodate interactions between case-mix factors and hospital
effects, but this leads to a large number of parameters to be estimated [25].
Addressing the variance decompositions in an explicit causal modeling framework
helps to answer questions regarding the part of the variation in care received that
is explained by different practices for similar patients. Furthermore, quantifying ex-
plained confounding due to observed case-mix factors into its own variance component
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Source of variation
Process/outcome Patient case-mix Between-hospital Residual
Partial
Variance 0.067 0.017 0.164
95% CI (0.062, 0.072) (0.014, 0.020) (0.158, 0.169)
Proportion 26.9% 6.9% 66.2%
95% CI (24.9%, 29.0%) (5.5%, 8.1%) (64.0%, 68.5%)
Partial-CKD
Variance 0.058 0.016 0.173
95% CI (0.052, 0.065) (0.012, 0.020) (0.165, 0.179)
Proportion 23.7% 6.3% 70.0%
95% CI (21.2%, 26.3%) (4.7%, 8.1%) (67.1%, 72.7%)
MIS
Variance 0.023 0.044 0.164
95% CI (0.019, 0.027) (0.039, 0.050) (0.158, 0.170)
Proportion 9.9% 19.0% 71.1%
95% CI (8.1%, 11.5%) (16.8%, 21.6%) (68.4%, 73.7%)
Readmission
Variance 0.0020 0.0001 0.0679
95% CI (0.0013, 0.0027) (< 0.0001, 0.0004) (0.0670, 0.0685)
Proportion 2.81% 0.16% 97.03%
95% CI (1.92%, 3.92%) (< 0.01%, 0.55%) (95.74%, 97.94%)
Table 2: Three-way variance decomposition for the observed variance in the four
different QIs. The numbers are absolute and proportional variances (95% CI = 95%
credible interval).
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helps to assess the usefulness of a given process or outcome in constructing a quality
indicator. Also, we note that, similar to random effect meta-analysis, the estima-
tion of the between-hospital variance component is weighted roughly in proportion to
the hospital-specific patient volumes, meaning that the unstable estimates of small
hospitals do not have undue influence on the estimation of this variance component.
Several extensions are possible. We split the total variance into that explained
by hospital performance, case-mix, and unexplained residual variance. However, we
did not separate between case-mix factors that capture disease progression and thus
directly (and justifiably) influence the treatment decisions, and those capturing dis-
parities in care, such as sociodemographic and socioeconomic factors. While the latter
can be confounders under the causal model, any variation in care received that is ex-
plained by such factors may be of interest in itself, and thus could be split into a
separate variance component. Of particular interest might be interactions between
hospital effects and sociodemographic/economic factors, which would imply that dis-
parities in care occur within hospitals.
In this paper we considered only a single layer of exposure hierarchy, such as
hospitals. We are currently working on extending the causal variance decompositions
to multiple layers of a hierarchy, such as surgeons within hospitals or referral networks
within administrative subregions. This will require introduction of multiple levels of
exposure, using notation similar to causal mediation analysis models [29], where the
causal pathway leads, for example, from hospital to surgeon to outcome. This will
enable us to further decompose the hospital effects to those due to institution level
factors and those resulting from practitioner level differences. However, since the
models with nested exposures are made identifiable through random effects, this will
require further consideration of the role of random effects in causal models.
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Figure 2: Simulated sampling distribution means for the three variance components
under both fixed and random effect models for the continuous outcomes under differ-
ent combinations of n (total number of patients) and m (total number of hospitals),
based on 1000 replications. The black dots indicate the true variances. Also shown
are the 95% quantile interval for the sampling distribution, and the 95% confidence
interval for the mean, reflecting the Monte Carlo error in the estimated mean of the
sampling distribution. FE and RE stand for fixed-effect and random-effect models.
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Figure 3: Density plots for the simulated sampling distributions of the case-mix and
between-hospital variance components with a continuous outcome, based on 1000
replications. n and m are the total number of patients and total number of hospitals.
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Figure 4: Simulated sampling distribution means for the between-hospital variance
components, using the proposed estimator, and random effect variance τ 2, based on
1000 replications. FE stands for fixed-effect model. n and m are the total number of
patients and total number of hospitals.
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Figure 5: Simulated sampling distribution means for the case-mix and between-
hospital variance components under both fixed and random effect models for the
binary outcomes under different combinations of n (total number of patients) and
m (total number of hospitals), based on 1000 replications. Also shown are the 95%
quantile interval for the sampling distribution, and the 95% confidence interval for the
mean. The black dots indicate the true variances. FE and RE stand for fixed-effect
and random-effect models.
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Figure 6: Density plots for the simulated sampling distributions of the case-mix
and between-hospital variance components with a binary outcome, based on 1000
replications. n and m are the total number of patients and total number of hospitals.
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